GSK acquires Frontier Biotechnologies

GSK agreed to acquire Frontier Biotechnologies. Reported deal value: $1B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-02-24. Figures and status may change as filings and press coverage update.

CANCELLATIONS Frontier Biotechnologies strikes up to $1 billion deal with GSK Feb 24 – Frontier Biotechnologies ​said ‌on Tuesday it has struck ‌a ​ deal ⁠with GSK , ⁠granting the British drugmaker worldwide ​rights to ⁠develop ⁠two small ​interfering RNA ​therapies targeting kidney ‌diseases in an ⁠agreement that could be ⁠worth up ‌to $1 ⁠ billion